Cargando…

Group sequential crossover trial designs with strong control of the familywise error rate

Crossover designs are an extremely useful tool to investigators, and group sequential methods have proven highly proficient at improving the efficiency of parallel group trials. Yet, group sequential methods and crossover designs have rarely been paired together. One possible explanation for this co...

Descripción completa

Detalles Bibliográficos
Autores principales: Grayling, Michael J., Wason, James M. S., Mander, Adrian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199128/
https://www.ncbi.nlm.nih.gov/pubmed/30393467
http://dx.doi.org/10.1080/07474946.2018.1466528
_version_ 1783365084132671488
author Grayling, Michael J.
Wason, James M. S.
Mander, Adrian P.
author_facet Grayling, Michael J.
Wason, James M. S.
Mander, Adrian P.
author_sort Grayling, Michael J.
collection PubMed
description Crossover designs are an extremely useful tool to investigators, and group sequential methods have proven highly proficient at improving the efficiency of parallel group trials. Yet, group sequential methods and crossover designs have rarely been paired together. One possible explanation for this could be the absence of a formal proof of how to strongly control the familywise error rate in the case when multiple comparisons will be made. Here, we provide this proof, valid for any number of initial experimental treatments and any number of stages, when results are analyzed using a linear mixed model. We then establish formulae for the expected sample size and expected number of observations of such a trial, given any choice of stopping boundaries. Finally, utilizing the four-treatment, four-period TOMADO trial as an example, we demonstrate that group sequential methods in this setting could have reduced the trials expected number of observations under the global null hypothesis by over 33%.
format Online
Article
Text
id pubmed-6199128
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-61991282018-10-31 Group sequential crossover trial designs with strong control of the familywise error rate Grayling, Michael J. Wason, James M. S. Mander, Adrian P. Seq Anal Original Articles Crossover designs are an extremely useful tool to investigators, and group sequential methods have proven highly proficient at improving the efficiency of parallel group trials. Yet, group sequential methods and crossover designs have rarely been paired together. One possible explanation for this could be the absence of a formal proof of how to strongly control the familywise error rate in the case when multiple comparisons will be made. Here, we provide this proof, valid for any number of initial experimental treatments and any number of stages, when results are analyzed using a linear mixed model. We then establish formulae for the expected sample size and expected number of observations of such a trial, given any choice of stopping boundaries. Finally, utilizing the four-treatment, four-period TOMADO trial as an example, we demonstrate that group sequential methods in this setting could have reduced the trials expected number of observations under the global null hypothesis by over 33%. Taylor & Francis 2018-10-02 /pmc/articles/PMC6199128/ /pubmed/30393467 http://dx.doi.org/10.1080/07474946.2018.1466528 Text en © 2018 The Authors. Published with license by Taylor & Francis Group, LLC. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Grayling, Michael J.
Wason, James M. S.
Mander, Adrian P.
Group sequential crossover trial designs with strong control of the familywise error rate
title Group sequential crossover trial designs with strong control of the familywise error rate
title_full Group sequential crossover trial designs with strong control of the familywise error rate
title_fullStr Group sequential crossover trial designs with strong control of the familywise error rate
title_full_unstemmed Group sequential crossover trial designs with strong control of the familywise error rate
title_short Group sequential crossover trial designs with strong control of the familywise error rate
title_sort group sequential crossover trial designs with strong control of the familywise error rate
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199128/
https://www.ncbi.nlm.nih.gov/pubmed/30393467
http://dx.doi.org/10.1080/07474946.2018.1466528
work_keys_str_mv AT graylingmichaelj groupsequentialcrossovertrialdesignswithstrongcontrolofthefamilywiseerrorrate
AT wasonjamesms groupsequentialcrossovertrialdesignswithstrongcontrolofthefamilywiseerrorrate
AT manderadrianp groupsequentialcrossovertrialdesignswithstrongcontrolofthefamilywiseerrorrate